All Posts

ABS CEO Eugene Williams joined Force Family Office for a webinar on precision medicine, biomarker-guided diagnosis, and ABS's immuno-corrective approach to autoimmune disease. ABS CEO Eugene Williams recently joined Force Family Office for a webinar on ABS's precision approach to autoimmune disease — an approach rooted in precision medicine, not broad immunosuppression. Today, 30–50% of patients with rheumatoid arthritis, lupus, type 1 diabetes, and other autoimmune diseases

Recognized For His Leadership in RNA Biology and the Scientific Foundation Driving Precision Autoimmune Disease Therapeutics, Dr. Garcia-Blanco continues to advance RNA-driven disease mechanisms. Autoimmunity BioSolutions (ABS), a biotechnology company developing a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor (sIL7R), today announced that company co-founder Dr. Mariano A. Garcia-Blanco has been electe